Kura Oncology (KURA) Misses Q1 EPS by 4c

Kura Oncology (NASDAQ: KURA) reported Q1 EPS of ($0.66), $0.04 worse than the analyst estimate of ($0.62). Revenue for the quarter came in at $14.11 million versus the consensus estimate of $13.37 million.

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• PG&E Corp, Edison spike on chatter
• Modern Chandelier's 2026 Design Report Identifies Six Directions Replacing Polished Chrome in American Homes
• Action Behavior Centers' Family Advocacy Team Meets with Congressional Leaders in Washington, D.C., to Discuss Access to ABA Therapy for Autism